Survey of low ER-positive expression and its correlation with other clinical and pathological factors in breast cancer | Zendy

Seyed-Hamid Madani | Zendy; Atena Azami | Zendy; Sedigheh Khazaei | Zendy; Babak Izadi | Zendy; Elahe Saleh | Zendy; Soraya Sajadimajd | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Survey of low ER-positive expression and its correlation with other clinical and pathological factors in breast cancer

Author(s) -

Seyed-Hamid Madani,

Atena Azami,

Sedigheh Khazaei,

Babak Izadi,

Elahe Saleh,

Soraya Sajadimajd

Publication year - 2020

Publication title -

indian journal of pathology and microbiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.217

H-Index - 31

eISSN - 0974-5130

pISSN - 0377-4929

DOI - 10.4103/ijpm.ijpm_255_17

Subject(s) - immunohistochemistry , breast cancer , estrogen receptor , her2/neu , medicine , lymph node , cancer , pathological , pathology , oncology , breast carcinoma , estrogen , progesterone receptor

Breast cancer is the most common cancer in women. Owning to the prominent role of biomarkers in molecular classification of breast cancer in recent years, evaluation of estrogen receptor (ER), progesterone receptor (PR), and Her2/neu seems to be required for prognosis and treatment of patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research